Skip to content
Nonprofiteer
← AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION

Form 990 for tax year 2024

Filed by AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION.

Totals

Total revenue
$3,585,475
Total expenses
$3,245,282
Contributions and grants received
$1,714,721
Grants paid
$730,281
Program service revenue
$1,199,097
Investment income
$671,657
Other revenue
$0
Total assets, end of year
$14,275,101
Total liabilities, end of year
$673,342
Net assets or fund balances, end of year
$13,601,759
Program services expenses (Part IX)
$2,103,974
Management and general expenses
$364,982
Fundraising expenses
$776,326
Program service expenses (Part III)
$2,103,974

Program services were 64.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1d · Related organizations

    $367,250

  • 1f · All other contributions, gifts and grants

    $1,347,471

  • 1g · Noncash contributions included above

    $10,301

  • 2a · Program service revenue: PHARMACY LEADERSHIP ACADEMY

    total $646,180 · related or exempt $646,180

  • 2b · Program service revenue: CORPORATE PARTNER PROGRAM

    total $517,917 · related or exempt $517,917

  • 2c · Program service revenue: SPONSORSHIPS

    total $35,000 · excluded $35,000

  • 3 · Investment income

    total $527,852 · excluded $527,852

  • 7a · Gross sales of assets other than inventory

    securities $1,003,374

  • 7b · Less cost or other basis and sales expenses

    securities $859,569

  • 7c · Gain or loss

    securities $143,805

  • 7d · Net gain or loss

    total $143,805 · excluded $143,805

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $677,495 · program services $677,495

  • 2 · Grants to domestic individuals

    total $52,786 · program services $52,786

  • 5 · Compensation of officers, directors and key employees

    total $1,121,931 · program services $575,422 · management and general $153,058 · fundraising $393,451

  • 7 · Other salaries and wages

    total $518,295 · program services $265,826 · management and general $70,708 · fundraising $181,761

  • 8 · Pension plan contributions

    total $33,625 · program services $17,246 · management and general $4,587 · fundraising $11,792

  • 9 · Other employee benefits

    total $12,051 · program services $6,181 · management and general $1,644 · fundraising $4,226

  • 10 · Payroll taxes

    total $101,600 · program services $52,109 · management and general $13,861 · fundraising $35,630

  • 11c · Fees: accounting

    total $13,750 · management and general $13,750

  • 11f · Fees: investment management

    total $5,740 · management and general $5,740

  • 11g · Fees: other

    total $421,685 · program services $351,763 · management and general $407 · fundraising $69,515

  • 13 · Office expenses

    total $59,399 · program services $45,429 · management and general $3,550 · fundraising $10,420

  • 17 · Travel

    total $156,186 · program services $26,740 · management and general $63,059 · fundraising $66,387

  • 22 · Depreciation, depletion and amortization

    total $29,977 · program services $29,977

  • 24a · Other expenses: BAD DEBT EXPENSE

    total $22,500 · management and general $22,500

  • 24b · Other expenses: CREDIT CARD FEES

    total $15,262 · management and general $12,118 · fundraising $3,144

  • 24c · Other expenses: HONORARIA

    total $3,000 · program services $3,000

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $38,721 · end of year $126,440

  • 3 · Pledges and grants receivable

    beginning of year $761,302 · end of year $670,868

  • 4 · Accounts receivable

    beginning of year $101,119 · end of year $48,791

  • 9 · Prepaid expenses and deferred charges

    beginning of year $50,671 · end of year $31,624

  • 10a · Land, buildings and equipment: cost or other basis

    $299,790

  • 10b · Land, buildings and equipment: accumulated depreciation

    $289,396

  • 10c · Land, buildings and equipment, net

    beginning of year $40,371 · end of year $10,394

  • 11 · Investments: publicly traded securities

    beginning of year $12,511,946 · end of year $13,277,956

  • 12 · Investments: other securities

    beginning of year $63,017 · end of year $557

  • 15 · Other assets

    beginning of year $5,423 · end of year $108,471

  • 17 · Accounts payable and accrued expenses

    beginning of year $135,070 · end of year $209,059

  • 19 · Deferred revenue

    beginning of year $466,133 · end of year $464,283

  • 25 · Other liabilities

    beginning of year $122,989 · end of year $0

  • 27 · Net assets without donor restrictions

    beginning of year $3,940,565 · end of year $4,457,187

  • 28 · Net assets with donor restrictions

    beginning of year $8,907,813 · end of year $9,144,572

Mission and programs · 2024

Mission

OUR MISSION: SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE, AND EFFECTIVE MEDICATION USE.

Activities or mission (Part I)

THE MISSION OF THE ASHP FOUNDATION IS TO SUPPORT ASHP BY ADVANCING (CONTINUED ON SCHEDULE O)THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE, AND EFFECTIVE MEDICATION USE.

  • EXCELLENCE IN PHARMACY PRACTICE AND LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACY. ASHP STUDENT LEADERSHIP AWARD: THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. TWELVE STUDENTS WHO DEMONSTRATED HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. THE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON THE IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM: SAMSON MEDICAL TECHNOLOGIES AND MEDI-DOSE SUPPORTED THE 2024 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. AWARDEES RECEIVE A PLAQUE AND PARTICIPATE IN SHORT INTERVIEWS AND ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR CLINICAL MEETING AND EXHIBITION (ASHP MIDYEAR). EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON RESIDENT PROFESSIONAL DEVELOPMENT TOPICS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. LITERATURE AWARDS PROGRAM: THE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, RECOGNIZES TO STIMULATE INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES WERE RECOGNIZED IN FIVE (5) DIFFERENT CATEGORIES IN 2024. AWARDEES RECEIVE AN HONORARIUM, PLAQUE, PARTICIPATE IN SHORT INTERVIEWS AND PODCASTS, AND ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR MEETING. MIDYEAR TRAVEL AWARD: THE MIDYEAR TRAVEL AWARD, ORIGINALLY CREATED AS A COLLABORATION BETWEEN THE ASHP FOUNDATION AND #PHARMGRADWISHLIST, AWARDED 32 PHARMD CANDIDATES WITH A $500 TRAVEL STIPEND, REGISTRATION TO THE ASHP MIDYEAR MEETING, AND A ONE-YEAR ASHP MEMBERSHIP. THERE WERE 260 APPLICATIONS RECEIVED FOR THE AWARD IN FY25. THE PROGRAM WAS PARTIALLY FUNDED VIA $25,000 DONATIONS EACH FROM MARVIN SAMSON AND APEXUS, ALONG WITH INDIVIDUAL DONATIONS. ASHP FOUNDATION PHARMACY STUDENT SCHOLARSHIP: IN FY25, THE ASHP FOUNDATION ENGAGED WITH SELECTED RECIPIENTS OF THE PHARMACY STUDENT SCHOLARSHIP. THE SCHOLARSHIP WAS AWARDED IN SPRING 2025 (FY24) THROUGH FOUR US-ACCREDITED HISTORICALLY BLACK COLLEGES AND UNIVERSITIES (HBCUS) SCHOOLS OF PHARMACY FOR THE 2024-2025 ACADEMIC YEAR. NO SCHOLARSHIPS WERE AWARDED THROUGH THIS PROGRAM IN FY25. PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM: SUPPORTED BY AN EDUCATIONAL GRANT FROM BAXTER AND OFFERED IN COLLABORATION WITH ASHP'S SECTION ON CLINICAL SPECIALISTS AND SCIENTISTS, THE PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM DISTANCE PROGRAM IS DESIGNED TO DEVELOP LEADERS WITH KNOWLEDGE AND SKILLS TO OPTIMIZE SAFE AND EFFECTIVE NUTRITIONAL SUPPORT NEEDS OF PATIENTS. A COHORT OF EIGHT PHARMACY RESIDENTS IN PGY2 PROGRAMS WERE SELECTED TO COMPLETE THE PROGRAM WITH THEIR PRECEPTOR. THE PREVIOUS COHORT COMPLETED THE EXPERIENTIAL PORTION OF THE PROGRAM THROUGHOUT FY25. THE APPLICATION FOR A NEW CYCLE OPENED IN FY25, WITH THE COHORT SELECTED IN FY26. MEDICATION SAFETY SCHOLARS: ASHP FOUNDATION IN PARTNERSHIP WITH EMILY JERRY FOUNDATION AND THE ASHP STUDENT FORUM SELECTED PARTICIPANTS FOR THE MEDICATION SAFETY SCHOLARS PROGRAM. THE COHORT PARTICIPATED IN A DISTANCE IMPACT PROGRAM STRUCTURED TO SUPPORT FIVE P2 AND P3 DOCTOR OF PHARMACY STUDENTS, PAIRED WITH ONE GROUP COACH, TO ENHANCE THEIR KNOWLEDGE AND SKILLS IN MEDICATION SAFETY. THE COHORT WILL HAVE A NETWORKING DINNER AND FINALIZE THEIR PROJECT IN FY26. PHARMACY RESIDENCY EXPANSION GRANT: IN FY25, SUPPORTED BY AN EDUCATIONAL DONATION FROM MERCK & CO., INC., RAHWAY, NJ, USA, THE ASHP FOUNDATION AWARDED A TOTAL OF $75,000 DOLLARS IN GRANTS TO THREE (3) PGY-1 AND PGY-2 PHARMACY RESIDENCY PROGRAMS TO INCREASE THE NUMBER OF AVAILABLE TRAINING POSITIONS. PHARMACY STUDENT CLINICAL SKILLS COMPETITION: GABRIELLA MIGNOSA AND EMMA VAN REYSEN FROM THE UNIVERSITY OF RHODE ISLAND COLLEGE OF PHARMACY COMPETED FOR THE 2024 ASHP NATIONAL CLINICAL SKILLS COMPETITION, AND WON THE COMPETITION IN DECEMBER 2024, DURING THE ASHP MIDYEAR CLINICAL MEETING IN NEW ORLEANS, LA. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING FOR 19 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN.EXCELLENCE IN RESIDENCY: FUNDED THROUGH THE DANIEL M. ASHBY FUND FOR EXCELLENCE IN PHARMACY RESIDENCY TRAINING, THE FOUNDATION CONTRACTED WITH UNIVERSITY OF GEORGIA (UGA) AND ASHP'S ACCREDITATION SERVICES DIVISION ON A GRANT TO UGA AND SUBSEQUENT RESEARCH PROJECT TO STUDY RESIDENTS' PROGRAM EXPERIENCES AND COMPLETION. PHARMACY LEADERSHIP ACADEMY (PLA): THE PLA, SUPPORTED IN PART BY A DONATION FROM APEXUS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS AND PHARMACY TECHNICIANS. THE PLA CLASS IN FY25 CONSISTED OF 104 PARTICIPANTS, WHO ALSO REMITTED TUITION AND WERE ENROLLED IN THE PROGRAM FROM JULY 2024 TO JUNE 2025. THE NUMBER OF GRADUATES FROM THIS CLASS BRINGS THE TOTAL NUMBER OF PLA GRADUATES ALMOST 1,400.WILLIAM A. ZELLMER LEADERSHIP LECTURE: WHERE PRACTICE MEETS POLICY:THIS ANNUAL LUNCHEON-LECTURE EVENT, HOSTED BY ASHP IN PARTNERSHIP WITH THE ASHP FOUNDATION, IS DESIGNED TO HONOR THE DISTINGUISHED 40-YEAR ASHP CAREER OF WILLIAM A. ZELLMER AND IS SUPPORTED BY DONORS TO THE ASHP FOUNDATION'S WILLIAM ZELLMER FUND. COL. WILLIAM MICHAEL HEATH, MBA PRESENTED THE LECTURE ON SEPTEMBER 17, 2024, DURING ASHP'S ANNUAL POLICY WEEK ACTIVITIES. JOSEPH A. ODDIS ETHICS COLLOQUIUM:THE JOSEPH A. ODDIS ETHICS COLLOQUIUM FOCUSED ON THE TOPICS: ETHICAL DIMENSION OF ARTIFICIAL INTELLIGENCE (AI) IN PHARMACY. THE SESSION WAS PLANNED AND LED BY THE PROGRAM CHAIR IN JUNE DURING THE 2024 ASHP PHARMACY FUTURES MEETING IN PORTLAND, OR.STRATEGIC EXECUTION PROJECT:SUPPORTED BY A DONATION FROM OMNICELL, INC. AND FUNDS FROM THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND MARIANNE F. IVEY FUND FOR PHARMACY LEADERSHIP DEVELOPMENT, A SURVEY PROJECT WAS LAUNCHED TO EXPLORE THE CURRENT STATE OF STRATEGIC PLANNING AND EXECUTION. A GOAL OF THE PROJECT IS TO PREPARE TOMORROW'S GENERATION OF PHARMACY LEADERS, BY UNDERSTANDING HOW THE LEADERS OF TODAY OPERATE THROUGH A SURVEY AND ANALYSIS OF THE RESULTS. HEALTH SYSTEM PHARMACY LEADERS WERE RECRUITED TO ADVISE ON THE DEVELOPMENT OF THE SURVEY AND ANALYSIS OF THE RESULTS. A MANUSCRIPT OF THE SURVEY RESULTS WAS SUBMITTED TO AJHP IN OCTOBER 2025. PLANNED FOR SPRING 2026 IS A RESULTS OVERVIEW INFOGRAPHIC AND A VIRTUAL NETWORKING SESSION TO ENGAGE LEADERS IN THE RESULTS AND PLANNING FUTURE ACTIVITIES.ASHP NATIONAL PUBLIC AWARENESS CAMPAIGN: THIS GRANT TO ASHP WAS PROVIDED TO SUPPORT THE DEVELOPMENT AND IMPLEMENTATION OF THE ASHP NATIONAL PUBLIC AWARENESS CAMPAIGN. THE GOAL OF THE PROJECT IS TO HAVE A COMPREHENSIVE NATIONAL AWARENESS CAMPAIGN TO BRING VISIBILITY AND RECOGNITION TO THE CRITICAL AND DIVERSE ROLES OF PHARMACISTS AND PHARMACY TECHNICIANS IN HOSPITALS AND HEALTH SYSTEMS.VISITING LEADERS PROGRAM (VLP): THE VISITING LEADERS PROGRAM, WITH SUPPORT FROM THE SARA J. WHITE LEADERSHIP FUND AND DAVID A. ZILZ LEADERS FOR THE FUTURE FUND, HAD ANOTHER SUCCESSFUL YEAR. NINE LEADERS WERE INVOLVED IN 16 RESIDENCY VISITS TO DISCUSS EMERGING LEADERSHIP TOPICS WITH PHARMACY RESIDENTS AND PRECEPTORS. SPECIALTY PHARMACY SURVEY:ASHP FOUNDATION PROVIDED THE REMAINING FUNDING OF $10,000 GRANTS TO ASHP FOR THE SPECIALTY PHARMACY SURVEY. THE INITIAL FUNDING WAS GRANTED IN FY24.

    Expenses $1,268,696 · Grants $432,392 · Revenue $1,164,097

  • Withheld by Nonprofiteer: this text may name a private individual.

    Expenses $835,278 · Grants $297,889

  • THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS.

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.

Listed in Part VII

  • Kelly McCormick-Sullivan

    SECRETARY AND CEO

    Total calculated
    $207,073
    From this org
    $185,739
    From related orgs
    $0
    Other
    $21,334
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $185,118
    Bonus
    $0
    Other
    $621
    Deferred
    $542
    Nontaxable benefits
    $20,792
    Filer's total
    $207,073
  • Kelly M Smith

    CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Ken Perez

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Paul W Abramowitz

    PRESIDENT

    Total calculated
    $1,231,032
    From this org
    $0
    From related orgs
    $1,165,359
    Other
    $65,673
    Hours/week
    2 + 38 related

    Schedule J breakdown matched by us

    Base
    $0 + $987,799 related
    Bonus
    $0 + $147,597 related
    Other
    $0 + $29,963 related
    Deferred
    $0 + $33,600 related
    Nontaxable benefits
    $0 + $32,073 related
    Filer's total
    $0 + $1,231,032 related
  • Christene Jolowsky

    TREASURER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Roger Anderson

    DIRECTOR AT LARGE

    Total calculated
    $0
    Hours/week
    1
  • Chris Hatwig

    DIRECTOR AT LARGE

    Total calculated
    $0
    Hours/week
    1
  • Wendy Horton

    DIRECTOR AT LARGE

    Total calculated
    $800
    From this org
    $0
    From related orgs
    $800
    Other
    $0
    Hours/week
    1
  • Ellen Menard

    DIRECTOR AT LARGE

    Total calculated
    $0
    Hours/week
    1
  • Thomas J Rice

    DIRECTOR AT LARGE

    Total calculated
    $0
    Hours/week
    1
  • Scott M Samson

    DIRECTOR AT LARGE

    Total calculated
    $0
    Hours/week
    1
  • Lindsey Thomas

    DIRECTOR AT LARGE

    Total calculated
    $0
    Hours/week
    1
  • Jon Zwinski

    DIRECTOR AT LARGE

    Total calculated
    $0
    Hours/week
    1
  • Nishaminy Kasbekar

    IMMEDIATE PAST PRESIDENT OF ASHP

    Total calculated
    $10,000
    From this org
    $0
    From related orgs
    $10,000
    Other
    $0
    Hours/week
    1 + 2 related
  • Leigh Briscoe-Dwyer

    PRESIDENT OF ASHP

    Total calculated
    $10,000
    From this org
    $0
    From related orgs
    $10,000
    Other
    $0
    Hours/week
    1 + 5 related
  • Barbara Nussbaum

    VP, RESEARCH AND EDUCATION

    Total calculated
    $263,461
    From this org
    $206,516
    From related orgs
    $0
    Other
    $56,945
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $200,737
    Bonus
    $3,809
    Other
    $1,970
    Deferred
    $21,214
    Nontaxable benefits
    $35,731
    Filer's total
    $263,461
  • Martha Crews

    VP, DEVELOPMENT

    Total calculated
    $198,768
    From this org
    $148,601
    From related orgs
    $0
    Other
    $50,167
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $144,492
    Bonus
    $2,755
    Other
    $1,354
    Deferred
    $15,346
    Nontaxable benefits
    $34,821
    Filer's total
    $198,768
  • Stephanie Brown

    SENIOR DIRECTOR, OPERATIONS

    Total calculated
    $163,412
    From this org
    $134,570
    From related orgs
    $0
    Other
    $28,842
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $131,676
    Bonus
    $2,380
    Other
    $514
    Deferred
    $13,258
    Nontaxable benefits
    $15,584
    Filer's total
    $163,412
  • Steven A Rubloff

    SECRETARY AND CEO

    Total calculated
    $289,219
    From this org
    $242,866
    From related orgs
    $0
    Other
    $46,353
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $178,795
    Bonus
    $0
    Other
    $64,071
    Deferred
    $28,567
    Nontaxable benefits
    $17,786
    Filer's total
    $289,219

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 6
PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.
PART I, LINE 7
ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Provenance

Return type
form_990
Tax year
2024
Filed
25 March 2026
IRS schema version
2024v5.5
Source object
202600899349300140

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.